Fatma B Rashidi Selected Research

gamma-Glutamyl Hydrolase (Carboxypeptidase G2)

4/2019	Production of "biobetter" variants of glucarpidase with enhanced enzyme activity.
1/2019	Production of "biobetter" glucarpidase variants to improve drug detoxification and antibody directed enzyme prodrug therapy for cancer treatment.
1/2018	Isolation and molecular characterization of novel glucarpidases: Enzymes to improve the antibody directed enzyme pro-drug therapy for cancer treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fatma B Rashidi Research Topics

Disease

4	Neoplasms (Cancer) 07/2019 - 01/2018
1	Hypotension (Low Blood Pressure) 07/2019
1	Sepsis (Septicemia) 07/2019

Drug/Important Bio-Agent (IBA)

3	glucarpidaseIBA 04/2019 - 01/2018
3	EnzymesIBA 04/2019 - 01/2018
3	ProdrugsIBA 04/2019 - 01/2018
3	gamma-Glutamyl Hydrolase (Carboxypeptidase G2)IBA 04/2019 - 01/2018
2	Methotrexate (Mexate)FDA LinkGeneric 04/2019 - 01/2018
2	Pharmaceutical PreparationsIBA 04/2019 - 01/2019
1	CytokinesIBA 07/2019
1	SuperantigensIBA 07/2019
1	AntigensIBA 07/2019
1	Peptides (Polypeptides)IBA 07/2019
1	EpitopesIBA 01/2018

Therapy/Procedure

3	Therapeutics 04/2019 - 01/2018
1	Immunotherapy 07/2019